Clincosm LogoSign in Get a demo

gastric cancer

Showing NaN - NaN of 116
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, Beijing, China
  • +10 more
Nov 23, 2023

Gastric Cancer, Pancreatic Cancer, Solid Tumor Trial in Beijing (KD-496)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • KD-496
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 15, 2023

Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis

Recruiting
  • Gastric Cancer
  • Gastric cancer
  • Beijing, China
  • +3 more
Oct 26, 2023

Gastric Cancer Response to Neoadjuvant Chemotherapy

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • Neoadjuvant Chemotherapy
  • Beijing, China
  • +21 more
Sep 6, 2023

Liquid Biopsy Signature to Detect Early-onset Gastric Cancer

Completed
  • Gastric Cancer
  • Measurement of levels of an exosome-based liquid biopsy signature
  • Beijing, Beijing, China
    Chinese PLA General Hospital Ethics Committee
Aug 29, 2023

Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 22, 2023

Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (AZD5863)

Recruiting
  • Gastric Cancer
  • +3 more
  • Jacksonville, Florida
  • +16 more
Aug 17, 2023

Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Beijing, China
    Beijing Cancer Hospital
Aug 7, 2023

Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced

Recruiting
  • Gastric Cancer
  • Gastric Adenocarcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Apr 4, 2023

Peritoneal Metastasis for Gastric Cancer Based on Radiomics

Recruiting
  • Gastric Cancer
  • Peritoneal Metastases
  • Peritoneal metastasis status ascertainment
  • Beijing, China
  • +12 more
Feb 12, 2023

Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S1)

Recruiting
  • Gastric Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Gastric Cancer Trial in Worldwide (AZD2936, MEDI5752, FOLFOX)

Recruiting
  • Gastric Cancer
  • Beijing, China
  • +25 more
Jan 18, 2023

Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)

Active, not recruiting
  • Stomach Neoplasms
  • +2 more
  • Beijing, China
  • +10 more
Dec 21, 2022

Gastric Cancer Trial in Worldwide (Bemarituzumab, Placebo, Modified FOLFOX6)

Completed
Has Results
  • Gastric Cancer
  • Bemarituzumab
  • +2 more
  • Tucson, Arizona
  • +188 more
Dec 15, 2022

Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients

Recruiting
  • Gastric Cancer
  • Chemotherapy Effect
  • Detection of levels of circulating EV-derived lncRNA-GC1
  • Beijing, Beijing, China
    Chinese PLA General Hospital Ethics Committee
Dec 12, 2022

Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma Trial in Worldwide (THOR-707, Pembrolizumab,

Active, not recruiting
  • Oesophageal Squamous Cell Carcinoma
  • +4 more
  • Duarte, California
  • +39 more
Oct 31, 2022

Gastric Cancer, Pancreatic Cancer, Solid Tumor Trial in Beijing (KD-496)

Recruiting
  • Gastric Cancer
  • +2 more
  • KD-496
  • Beijing, China
    Chinese PLA General Hospital
Oct 13, 2022

Neoadjuvant Chemotherapy and Immunotherapy for HER2(-),pMMR

Recruiting
  • Gastric Cancer
  • SOX plus Paclitaxel(albumin-bound) followed by PD-1 antibody
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Sep 12, 2022

Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • margetuximab
  • +4 more
  • Scottsdale, Arizona
  • +72 more
Aug 24, 2022

Nutrition Intervention Trials in Linxian Follow-up Study

Enrolling by invitation
  • Esophageal Cancer
  • Gastric Cancer
    • Beijing, China
      Cancer Institute and hospital, Chinese Academy of Medical Scienc
    Aug 24, 2022

    Gastric Cancer Trial in Beijing (RC48-ADC, RC98-ADC)

    Not yet recruiting
    • Gastric Cancer
    • Beijing, Beijing, China
      Remegen
    Aug 21, 2022

    Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (Pembrolizumab, Placebo, Cisplatin)

    Active, not recruiting
    • Gastric Cancer
    • Gastroesophageal Junction Cancer
    • Pembrolizumab
    • +7 more
    • Duarte, California
    • +170 more
    Aug 18, 2022

    Gastric Cancer, Gastroesophageal Junction Cancer Trial in China (Pembrolizumab, Placebo, Cisplatin)

    Recruiting
    • Gastric Cancer
    • Gastroesophageal Junction Cancer
    • Pembrolizumab
    • +7 more
    • Beijing, Beijing, China
    • +12 more
    Aug 17, 2022

    Gastric Cancer Trial in Beijing (S-1, Trastuzumab, Oxaliplatin)

    Completed
    • Gastric Cancer
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences
    Aug 14, 2022

    Gastric Cancer Trial in Beijing (Intraperitoneal chemo, Adjuvant systemic chemo)

    Recruiting
    • Gastric Cancer
    • Intraperitoneal chemotherapy
    • Adjuvant systemic chemotherapy
    • Beijing, Beijing, China
      National Cancer Center/National Clinical Research Center for Can
    Aug 10, 2022